Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
about
Immune mechanisms in malaria: new insights in vaccine developmentProfiling the host response to malaria vaccination and malaria challengeBoosting vaccine efficacy the natural (killer) wayLongevity and determinants of protective humoral immunity after pandemic influenza infection.CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01EIL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells.Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.Influenza vaccine induces intracellular immune memory of human NK cellsImpaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals.OMIP-025: evaluation of human T- and NK-cell responses including memory and follicular helper phenotype by intracellular cytokine staining.OMIP-024: pan-leukocyte immunophenotypic characterization of PBMC subsets in human samplesControlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming.Tailoring a Combination Preerythrocytic Malaria VaccineNK Cells: Uncertain Allies against Malaria.The robust and modulated biomarker network elicited by the Plasmodium vivax infection is mainly mediated by the IL-6/IL-10 axis and is associated with the parasite load.Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.Innate immunity against HIV-1 infection.Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial.Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.Distinct TH1 and TH2 cellular responses associated with malaria protection and risk in RTS,S/AS01E vaccinees.RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial.Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.Differential T-cell responses to a chimeric Plasmodium falciparum antigen; UB05-09, correlates with acquired immunity to malaria.Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine.The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination.CMV and natural killer cells: shaping the response to vaccination.Vaccinating for natural killer cell effector functions.Le vaccin antipaludique RTS,S/AS01 chez les enfants âgés de 5 à 17 mois au moment de la première vaccination
P2860
Q21032484-DB9509BB-6B23-4F27-AEA2-BEC7D2D8F4D9Q26800494-DB27922D-78E6-4285-A5FD-417AB379B733Q28084474-ABD6E8CE-9BB7-427C-9FF2-C647DDB61BEAQ30369770-05BD8D64-9D3C-4400-AE9D-B3EA893FF67FQ34057778-EDAB03B2-5025-4C8A-B5F1-DB56D481DD3CQ34541330-A83AEAD0-E7D1-44E0-9835-5621E606572DQ34651540-9DCD97E2-B141-4B76-B6CA-21ABFDCC99F7Q35126671-5043E004-E3D8-406E-8F4C-8CAB95DE72F0Q35189033-855DC0BD-836B-46C2-8C4F-A1A638A55659Q35560718-7D48D07C-E7A6-4F3C-B54A-458B30C6B1ABQ35680007-83899BDD-D58A-4F3E-8ED5-33AFB35C801EQ35688250-CA9A0723-7751-4C98-945A-821C3321E7BBQ36389006-F20FAA9B-88DA-44B3-A30A-3503F5AC181AQ36631331-EAC54821-E282-4072-9698-29C0F6568887Q37689434-61AFB002-ADA8-406E-A03A-1C69C7700083Q37704579-3F491132-F242-414C-AFEC-052F8E2DF4AEQ37710781-BE61461C-3D86-4E24-AC6E-B0DC81D4460AQ38491184-15733693-FD34-4052-B915-080312FB18C9Q38599514-FE7A127C-042C-427B-AA77-BB659F7449CBQ38739590-3CAC1ED9-BF42-4D9C-AC80-A84B4A8E2C2CQ38850734-68279F30-D750-4D2E-B415-B22DA50F4099Q39262417-32927FCA-0439-4C29-879A-4349F6AC3132Q40054719-38BF5702-4691-44DD-BB29-B49E605EDD62Q40064119-218D3B9C-7A5A-461C-B10E-CC40B1869910Q40112602-1AE7AC34-037B-4432-9E9D-C0B6F570D2EAQ41162993-A78608B8-113C-4847-BEDF-85AD89E21EF4Q41994662-D71B46EA-9D98-45A7-9220-777E838F0410Q44168441-B7896A3F-16FC-477B-A404-1162EC1CC255Q47977891-C7347A62-5F78-4F85-9880-0B7CB9B7C19CQ48273032-32AE833D-9063-4663-9237-EC2B79052B80Q50301007-84D92732-D4B6-4A57-9E17-C02355362AD2Q58131059-8953064C-A352-4729-B9FD-D27BB29D6258
P2860
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@ast
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@en
type
label
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@ast
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@en
prefLabel
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@ast
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@en
P2093
P2860
P50
P921
P356
P1476
Antigen-specific IL-2 secretio ...... he RTS,S/AS01 malaria vaccine.
@en
P2093
Amanda Leach
Amir Horowitz
Denise Dekker
Elizabeth King
Johan Vekemans
John Lusingu
Julius C R Hafalla
Patrick H Corran
Philippe Moris
P2860
P304
P356
10.4049/JIMMUNOL.1102710
P407
P577
2012-04-13T00:00:00Z